CONTENTS
Issue 99|October 2020
In association with
A look back over the history of innovations in antibody-based therapeutics
What can manufacturers do to ensure that they pass regulatory inspections
The 'love hormone' oxytocin may have therapeutic potential
AI-enabled risk detection could finesse the pharmaceutical supply chain
The long-term health effects of Covid-19 may put more pressure on the pharma industry
Exploring the latest developments in retinitis pigmentosa gene therapies
Investment in the fertility sector is growing thanks to novel research projects
Novel drug developments could improve symptom control for coeliac patients
Why are many pharma company PV departments failing to automate data capture?
Harnessing compliance as a lever for doing better business and enhancing market trust